ورود
مقالات فارسیISIکنفرانسهاژورنالها

Probiotic Lactobacillus plantarum may reduce cardiovascular risk: An experimental study

محل انتشار: مجله آریا آترواسکلروز، دوره: 17، شماره: 1
سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 92

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:
https://civilica.com/doc/1504198

شناسه ملی سند علمی:

JR_RYA-17-1_023

تاریخ نمایه سازی: 2 شهریور 1401

چکیده مقاله:

BACKGROUND: Reduction of cardiovascular risk (CVR) is based on the correction of risk factors, especially dyslipidemia. Due to the limiting factors of conventional lipid-lowering medications, the investigation of alternative approaches is necessary.METHODS: The present open, comparative, randomized, and parallel investigation was conducted on ۷۷ patients. Participants were of both sexes, ۴۰-۷۴ years-of-age, and had dyslipidemia. The participants were divided into ۲ groups; the treatment group (n = ۴۱) received a combination of Lactobacillus plantarum and simvastatin ۲۰ mg once a day, and the control group (n = ۳۶) received simvastatin ۲۰ mg once a day. The trial included ۵ visits; screening on the first ۲, and treatment on the next ۳ (on weeks ۴, ۸, and ۱۲). On visits ۱, ۳, ۴, and ۵, the lipid profile was evaluated and CVR was calculated using ۵ tools.RESULTS: The combination treatment led to a more pronounced decrease in total cholesterol (TC) and low-density lipoproteins (LDL) after ۸ weeks (P = ۰.۰۰۲ and ۰.۰۱۶, respectively), that persisted after ۱۲ weeks (P < ۰.۰۰۱ and ۰.۰۰۲, respectively). Reduction in TC and LDL by ³ ۲۰% was observed more predominantly in the treatment group. A significant reduction was observed in CVR in the treatment group according to the Prospective Cardiovascular Münster (‎PROCAM) score (P = ۰.۰۰۴). Reduction of CVR by ³ ۲۰% was mostly observed as a result of prescribing combination therapy according to the Framingham Risk Score ‎(۷۰.۷%; P = ۰.۰۰۳), ۲۰۱۳ ACC/AHA ASCVD Risk Calculator ‎(۵۱.۲%; P = ۰.۰۳۵), PROCAM (۶۵.۹%; P < ۰.۰۰۱), and WHO CVD risk chart (۵۶.۱%; P = ۰.۰۱۲).CONCLUSION: Additional supplementation with Lactobacillus plantarum was more effective in the reduction of TC, LDL, and CVR according to PROCAM and the attainment of treatment goals regarding lipid profile and CVR levels.

کلیدواژه ها:

Dyslipidemias ، Heart Disease Risk Factors ، Lactobacillus Plantarum

نویسندگان

Artem Neverovskyi

PhD Candidate, Department of Internal Medicine №۱, Bogomolets National Medical University, Kyiv, Ukraine

Volodymyr Chernyavskyi

Professor, Department of Internal Medicine №۱, Bogomolets National Medical University, Kyiv, Ukraine

Vadym Shypulin

Professor, Head of the Department, Department of Internal Medicine №۱, Bogomolets National Medical University, Kyiv, Ukraine

Lesia Hvozdetska

Associate Professor, Department of Internal Medicine №۱, Bogomolets National Medical University, Kyiv, Ukraine

Victoriya Tishchenko

Associate Professor, Department of Internal Medicine №۱, Bogomolets National Medical University, Kyiv, Ukraine

Tetyana Nechypurenko

Associate Professor, Department of Internal Medicine №۱, Bogomolets National Medical University, Kyiv, Ukraine

Nataliia Mikhn`ova

Associate Professor, Department of Internal Medicine №۱, Bogomolets National Medical University, Kyiv, Ukraine

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Mensah GA, Roth GA, Fuster V. The global burden of ...
  • World Health Organization cardiovascular disease risk charts: Revised models to ...
  • Global, regional, and national age-sex-specific mortality for ۲۸۲ causes of ...
  • Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, ...
  • Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, ...
  • Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, ...
  • Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, ...
  • Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, ...
  • D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain ...
  • Assmann G, Cullen P, Schulte H. Simple scoring scheme for ...
  • Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, ...
  • Lye HS, Rusul G, Liong MT. Removal of cholesterol by ...
  • Lew LC, Choi SB, Khoo BY, Sreenivasan S, Ong KL, ...
  • Qu T, Yang L, Wang Y, Jiang B, Shen M, ...
  • Yao C, Tian W, Song J, Wang J. Antihyperlipidaemic effect ...
  • Sharma S, Kurpad AV, Puri S. Potential of probiotics in ...
  • Wang L, Guo MJ, Gao Q, Yang JF, Yang L, ...
  • Wang G, Huang W, Xia Y, Xiong Z, Ai L. ...
  • Huang CH, Ho CY, Chen CT, Hsu HF, Lin YH. ...
  • Geng W, Lin J. Bacterial bile salt hydrolase: An intestinal ...
  • Choi SB, Lew LC, Yeo SK, Nair PS, Liong MT ...
  • Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and ...
  • Shypulin V, Chernyavskyi A, Neverovskyi L. Hypolipidemic efficacy of the ...
  • Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi ...
  • Goff DC, Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino ...
  • Wu Y, Zhang Q, Ren Y, Ruan Z. Effect of ...
  • Park YE, Kim MS, Shim KW, Kim YI, Chu J, ...
  • Reis SA, Conceicao LL, Rosa DD, Siqueira NP, Peluzio MCG. ...
  • Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, ...
  • Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, ...
  • Cole TB. Smoking cessation and reduction of cardiovascular disease risk. ...
    • نمایش کامل مراجع